시장조사 보고서 : 세계의 종양학 기반 전임상 CRO 시장예측 2021년-2026년

■ 영문 제목 : Global Oncology Based Preclinical CRO Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K02249 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 103 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 종양학 기반 전임상 CRO의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (혈액암, 고형 종양, 기타)와 용도별 시장규모 (시험관 내, 생체 내) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 종양학 기반 전임상 CRO 시장 점유율
- 지역별 종양학 기반 전임상 CRO 시장규모
- 주요지역의 종류별 시장규모 (혈액암, 고형 종양, 기타)
- 주요지역의 용도별 시장규모 (시험관 내, 생체 내)
- 미주의 종양학 기반 전임상 CRO 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 종양학 기반 전임상 CRO 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 종양학 기반 전임상 CRO 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 종양학 기반 전임상 CRO 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 종양학 기반 전임상 CRO 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Crown Bioscience, Charles River, ICON, Eurofins Scientific, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory, MI Bioresearch, Champion Oncology, Wuxi AppTec., Xentech, Living Tumor Laboratory
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Oncology Based Preclinical CRO will have significant change from previous year. By the most conservative estimates of global Oncology Based Preclinical CRO market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 331.8 million in 2020. Over the next five years the Oncology Based Preclinical CRO market will register a 12.9% CAGR in terms of revenue, the global market size will reach US$ 538.4 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Based Preclinical CRO market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Blood Cancer
Solid Tumors
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
In Vitro
In Vivo

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Based Preclinical CRO Market Size 2016-2026
2.1.2 Oncology Based Preclinical CRO Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Oncology Based Preclinical CRO Segment by Type
2.2.1 Blood Cancer
2.2.2 Blood Cancer
2.2.3 Others
2.3 Oncology Based Preclinical CRO Market Size by Type
2.3.1 Global Oncology Based Preclinical CRO Market Size CAGR by Type
2.3.2 Global Oncology Based Preclinical CRO Market Size Market Share by Type (2016-2021)
2.4 Oncology Based Preclinical CRO Segment by Application
2.4.1 In Vitro
2.4.2 In Vivo
2.5 Oncology Based Preclinical CRO Market Size by Application
2.5.1 Global Oncology Based Preclinical CRO Market Size CAGR by Application
2.5.2 Global Oncology Based Preclinical CRO Market Size Market Share by Application (2016-2021)

3 Oncology Based Preclinical CRO Market Size by Players
3.1 Oncology Based Preclinical CRO Market Size Market Share by Players
3.1.1 Global Oncology Based Preclinical CRO Revenue by Players (2019-2021E)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Players (2019-2021E)
3.2 Global Oncology Based Preclinical CRO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Oncology Based Preclinical CRO by Regions
4.1 Oncology Based Preclinical CRO Market Size by Regions (2016-2021)
4.2 Americas Oncology Based Preclinical CRO Market Size Growth (2016-2021)
4.3 APAC Oncology Based Preclinical CRO Market Size Growth (2016-2021)
4.4 Europe Oncology Based Preclinical CRO Market Size Growth (2016-2021)
4.5 Middle East & Africa Oncology Based Preclinical CRO Market Size Growth (2016-2021)

5 Americas
5.1 Americas Oncology Based Preclinical CRO Market Size by Country (2016-2021)
5.2 Americas Oncology Based Preclinical CRO Market Size by Type (2016-2021)
5.3 Americas Oncology Based Preclinical CRO Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Oncology Based Preclinical CRO Market Size by Region (2016-2021)
6.2 APAC Oncology Based Preclinical CRO Market Size by Type (2016-2021)
6.3 APAC Oncology Based Preclinical CRO Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Oncology Based Preclinical CRO by Country (2016-2021)
7.2 Europe Oncology Based Preclinical CRO Market Size by Type (2016-2021)
7.3 Europe Oncology Based Preclinical CRO Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Oncology Based Preclinical CRO by Region (2016-2021)
8.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2016-2021)
8.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Oncology Based Preclinical CRO Market Forecast
10.1 Global Oncology Based Preclinical CRO Forecast by Regions (2021-2026)
10.1.1 Global Oncology Based Preclinical CRO Forecast by Regions (2021-2026)
10.1.2 Americas Oncology Based Preclinical CRO Forecast
10.1.3 APAC Oncology Based Preclinical CRO Forecast
10.1.4 Europe Oncology Based Preclinical CRO Forecast
10.1.5 Middle East & Africa Oncology Based Preclinical CRO Forecast
10.2 Americas Oncology Based Preclinical CRO Forecast by Countries (2021-2026)
10.2.1 United States Oncology Based Preclinical CRO Market Forecast
10.2.2 Canada Oncology Based Preclinical CRO Market Forecast
10.2.3 Mexico Oncology Based Preclinical CRO Market Forecast
10.2.4 Brazil Oncology Based Preclinical CRO Market Forecast
10.3 APAC Oncology Based Preclinical CRO Forecast by Region (2021-2026)
10.3.1 China Oncology Based Preclinical CRO Market Forecast
10.3.2 Japan Oncology Based Preclinical CRO Market Forecast
10.3.3 Korea Oncology Based Preclinical CRO Market Forecast
10.3.4 Southeast Asia Oncology Based Preclinical CRO Market Forecast
10.3.5 India Oncology Based Preclinical CRO Market Forecast
10.3.6 Australia Oncology Based Preclinical CRO Market Forecast
10.4 Europe Oncology Based Preclinical CRO Forecast by Country (2021-2026)
10.4.1 Germany Oncology Based Preclinical CRO Market Forecast
10.4.2 France Oncology Based Preclinical CRO Market Forecast
10.4.3 UK Oncology Based Preclinical CRO Market Forecast
10.4.4 Italy Oncology Based Preclinical CRO Market Forecast
10.4.5 Russia Oncology Based Preclinical CRO Market Forecast
10.5 Middle East & Africa Oncology Based Preclinical CRO Forecast by Region (2021-2026)
10.5.1 Egypt Oncology Based Preclinical CRO Market Forecast
10.5.2 South Africa Oncology Based Preclinical CRO Market Forecast
10.5.3 Israel Oncology Based Preclinical CRO Market Forecast
10.5.4 Turkey Oncology Based Preclinical CRO Market Forecast
10.5.5 GCC Countries Oncology Based Preclinical CRO Market Forecast
10.6 Global Oncology Based Preclinical CRO Forecast by Type (2021-2026)
10.7 Global Oncology Based Preclinical CRO Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Information
11.1.2 Crown Bioscience Oncology Based Preclinical CRO Product Offered
11.1.3 Crown Bioscience Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Crown Bioscience Main Business Overview
11.1.5 Crown Bioscience Latest Developments
11.2 Charles River
11.2.1 Charles River Company Information
11.2.2 Charles River Oncology Based Preclinical CRO Product Offered
11.2.3 Charles River Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Charles River Main Business Overview
11.2.5 Charles River Latest Developments
11.3 ICON
11.3.1 ICON Company Information
11.3.2 ICON Oncology Based Preclinical CRO Product Offered
11.3.3 ICON Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 ICON Main Business Overview
11.3.5 ICON Latest Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Information
11.4.2 Eurofins Scientific Oncology Based Preclinical CRO Product Offered
11.4.3 Eurofins Scientific Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Eurofins Scientific Main Business Overview
11.4.5 Eurofins Scientific Latest Developments
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Information
11.5.2 Taconic Biosciences Oncology Based Preclinical CRO Product Offered
11.5.3 Taconic Biosciences Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Taconic Biosciences Main Business Overview
11.5.5 Taconic Biosciences Latest Developments
11.6 Covance
11.6.1 Covance Company Information
11.6.2 Covance Oncology Based Preclinical CRO Product Offered
11.6.3 Covance Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Covance Main Business Overview
11.6.5 Covance Latest Developments
11.7 EVOTEC
11.7.1 EVOTEC Company Information
11.7.2 EVOTEC Oncology Based Preclinical CRO Product Offered
11.7.3 EVOTEC Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 EVOTEC Main Business Overview
11.7.5 EVOTEC Latest Developments
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Information
11.8.2 The Jackson Laboratory Oncology Based Preclinical CRO Product Offered
11.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 The Jackson Laboratory Main Business Overview
11.8.5 The Jackson Laboratory Latest Developments
11.9 MI Bioresearch
11.9.1 MI Bioresearch Company Information
11.9.2 MI Bioresearch Oncology Based Preclinical CRO Product Offered
11.9.3 MI Bioresearch Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 MI Bioresearch Main Business Overview
11.9.5 MI Bioresearch Latest Developments
11.10 Champion Oncology
11.10.1 Champion Oncology Company Information
11.10.2 Champion Oncology Oncology Based Preclinical CRO Product Offered
11.10.3 Champion Oncology Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Champion Oncology Main Business Overview
11.10.5 Champion Oncology Latest Developments
11. Wuxi AppTec.
11.11.1 Wuxi AppTec. Company Information
11.11.2 Wuxi AppTec. Oncology Based Preclinical CRO Product Offered
11.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Wuxi AppTec. Main Business Overview
11.11.5 Wuxi AppTec. Latest Developments
11.12 Xentech
11.12.1 Xentech Company Information
11.12.2 Xentech Oncology Based Preclinical CRO Product Offered
11.12.3 Xentech Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Xentech Main Business Overview
11.12.5 Xentech Latest Developments
11.13 Living Tumor Laboratory
11.13.1 Living Tumor Laboratory Company Information
11.13.2 Living Tumor Laboratory Oncology Based Preclinical CRO Product Offered
11.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Living Tumor Laboratory Main Business Overview
11.13.5 Living Tumor Laboratory Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Oncology Based Preclinical CRO Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Blood Cancer
Table 3. Major Players of Solid Tumors
Table 4. Major Players of Others
Table 5. Oncology Based Preclinical CRO Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Oncology Based Preclinical CRO Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Oncology Based Preclinical CRO Market Size Market Share by Type (2016-2021)
Table 8. Oncology Based Preclinical CRO Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Oncology Based Preclinical CRO Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Oncology Based Preclinical CRO Market Size Market Share by Application (2016-2021)
Table 11. Global Oncology Based Preclinical CRO Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Oncology Based Preclinical CRO Revenue Market Share by Players (2019-2021E)
Table 13. Oncology Based Preclinical CRO Key Players Head office and Products Offered
Table 14. Oncology Based Preclinical CRO Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oncology Based Preclinical CRO Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Oncology Based Preclinical CRO Market Size Market Share by Regions 2016-2021
Table 19. Americas Oncology Based Preclinical CRO Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Oncology Based Preclinical CRO Market Size Market Share by Country (2016-2021)
Table 21. Americas Oncology Based Preclinical CRO Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Oncology Based Preclinical CRO Market Size Market Share by Type (2016-2021)
Table 23. Americas Oncology Based Preclinical CRO Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Oncology Based Preclinical CRO Market Size Market Share by Application (2016-2021)
Table 25. APAC Oncology Based Preclinical CRO Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Oncology Based Preclinical CRO Market Size Market Share by Region (2016-2021)
Table 27. APAC Oncology Based Preclinical CRO Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Oncology Based Preclinical CRO Market Size Market Share by Type (2016-2021)
Table 29. APAC Oncology Based Preclinical CRO Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Oncology Based Preclinical CRO Market Size Market Share by Application (2016-2021)
Table 31. Europe Oncology Based Preclinical CRO Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Oncology Based Preclinical CRO Market Size Market Share by Country (2016-2021)
Table 33. Europe Oncology Based Preclinical CRO Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Oncology Based Preclinical CRO Market Size Market Share by Type (2016-2021)
Table 35. Europe Oncology Based Preclinical CRO Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Oncology Based Preclinical CRO Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Oncology Based Preclinical CRO Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Oncology Based Preclinical CRO
Table 44. Key Application and Potential Industries of Oncology Based Preclinical CRO
Table 45. Key Challenges of Oncology Based Preclinical CRO
Table 46. Key Trends of Oncology Based Preclinical CRO
Table 47. Global Oncology Based Preclinical CRO Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Oncology Based Preclinical CRO Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Oncology Based Preclinical CRO Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Oncology Based Preclinical CRO Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Oncology Based Preclinical CRO Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Oncology Based Preclinical CRO Market Size Market Share Forecast by Application (2021-2026)
Table 53. Crown Bioscience Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 54. Crown Bioscience Oncology Based Preclinical CRO Product Offered
Table 55. Crown Bioscience Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Crown Bioscience Main Business
Table 57. Crown Bioscience Latest Developments
Table 58. Charles River Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 59. Charles River Oncology Based Preclinical CRO Product Offered
Table 60. Charles River Main Business
Table 61. Charles River Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Charles River Latest Developments
Table 63. ICON Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 64. ICON Oncology Based Preclinical CRO Product Offered
Table 65. ICON Main Business
Table 66. ICON Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. ICON Latest Developments
Table 68. Eurofins Scientific Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 69. Eurofins Scientific Oncology Based Preclinical CRO Product Offered
Table 70. Eurofins Scientific Main Business
Table 71. Eurofins Scientific Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Eurofins Scientific Latest Developments
Table 73. Taconic Biosciences Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 74. Taconic Biosciences Oncology Based Preclinical CRO Product Offered
Table 75. Taconic Biosciences Main Business
Table 76. Taconic Biosciences Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Taconic Biosciences Latest Developments
Table 78. Covance Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 79. Covance Oncology Based Preclinical CRO Product Offered
Table 80. Covance Main Business
Table 81. Covance Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Covance Latest Developments
Table 83. EVOTEC Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 84. EVOTEC Oncology Based Preclinical CRO Product Offered
Table 85. EVOTEC Main Business
Table 86. EVOTEC Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. EVOTEC Latest Developments
Table 88. The Jackson Laboratory Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 89. The Jackson Laboratory Oncology Based Preclinical CRO Product Offered
Table 90. The Jackson Laboratory Main Business
Table 91. The Jackson Laboratory Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. The Jackson Laboratory Latest Developments
Table 93. MI Bioresearch Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 94. MI Bioresearch Oncology Based Preclinical CRO Product Offered
Table 95. MI Bioresearch Main Business
Table 96. MI Bioresearch Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. MI Bioresearch Latest Developments
Table 98. Champion Oncology Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 99. Champion Oncology Oncology Based Preclinical CRO Product Offered
Table 100. Champion Oncology Main Business
Table 101. Champion Oncology Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Champion Oncology Latest Developments
Table 103. Wuxi AppTec. Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 104. Wuxi AppTec. Oncology Based Preclinical CRO Product Offered
Table 105. Wuxi AppTec. Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Wuxi AppTec. Main Business
Table 107. Wuxi AppTec. Latest Developments
Table 108. Xentech Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 109. Xentech Oncology Based Preclinical CRO Product Offered
Table 110. Xentech Main Business
Table 111. Xentech Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. Xentech Latest Developments
Table 113. Living Tumor Laboratory Details, Company Type, Oncology Based Preclinical CRO Area Served and Its Competitors
Table 114. Living Tumor Laboratory Oncology Based Preclinical CRO Product Offered
Table 115. Living Tumor Laboratory Main Business
Table 116. Living Tumor Laboratory Oncology Based Preclinical CRO Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. Living Tumor Laboratory Latest Developments
List of Figures
Figure 1. Oncology Based Preclinical CRO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Based Preclinical CRO Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Oncology Based Preclinical CRO Market Size Market Share by Type in 2020
Figure 7. Oncology Based Preclinical CRO in In Vitro
Figure 8. Global Oncology Based Preclinical CRO Market: In Vitro (2016-2021) & ($ Millions)
Figure 9. Oncology Based Preclinical CRO in In Vivo
Figure 10. Global Oncology Based Preclinical CRO Market: In Vivo (2016-2021) & ($ Millions)
Figure 11. Global Oncology Based Preclinical CRO Market Size Market Share by Application in 2020
Figure 12. Global Oncology Based Preclinical CRO Revenue Market Share by Player in 2020
Figure 13. Global Oncology Based Preclinical CRO Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Oncology Based Preclinical CRO Market Size 2016-2021 ($ Millions)
Figure 15. APAC Oncology Based Preclinical CRO Market Size 2016-2021 ($ Millions)
Figure 16. Europe Oncology Based Preclinical CRO Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Oncology Based Preclinical CRO Market Size 2016-2021 ($ Millions)
Figure 18. Americas Oncology Based Preclinical CRO Market Size Market Share by Country in 2020
Figure 19. Americas Oncology Based Preclinical CRO Market Size Market Share by Type in 2020
Figure 20. Americas Oncology Based Preclinical CRO Market Size Market Share by Application in 2020
Figure 21. United States Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Oncology Based Preclinical CRO Market Size Market Share by Regions in 2020
Figure 25. APAC Oncology Based Preclinical CRO Market Size Market Share by Type in 2020
Figure 26. APAC Oncology Based Preclinical CRO Market Size Market Share by Application in 2020
Figure 27. China Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Oncology Based Preclinical CRO Market Size Market Share by Country in 2020
Figure 34. Europe Oncology Based Preclinical CRO Market Size Market Share by Type in 2020
Figure 35. Europe Oncology Based Preclinical CRO Market Size Market Share by Application in 2020
Figure 36. Germany Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Oncology Based Preclinical CRO Market Size Market Share by Application in 2020
Figure 44. Egypt Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Oncology Based Preclinical CRO Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 50. APAC Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 51. Europe Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 53. United States Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 54. Canada Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 57. China Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 58. Japan Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 59. Korea Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 61. India Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 62. Australia Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 63. Germany Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 64. France Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 65. UK Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 66. Italy Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 67. Russia Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 68. Spain Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 71. Israel Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Oncology Based Preclinical CRO Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 종양학 기반 전임상 CRO 시장예측 2021년-2026년] (코드 : LPI-2201K02249) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 종양학 기반 전임상 CRO 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 혈액 종양 검사 시장예측 2021년-2026년
LPI-2201K00211 / LP Information / 2021년 12월 / 본 조사보고서는 혈액 종양 검사의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Hemato Oncology Testing will have significant change from previous year. By the most conservative estimates of global Hemato Oncology Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 면역종양학 시장예측 2021년-2026년
LPI-2201K00152 / LP Information / 2021년 12월 / 본 조사보고서는 면역종양학의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2021 growth of Immuno-Oncology will have significant change from previous year. By the most conservative estimates of global Immuno-Oncology market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 37120 million in 2020. Over the next...

세계의 면역종양학 임상시험 시장예측 2021년-2026년
LPI-2201K00153 / LP Information / 2021년 12월 / 본 조사보고서는 면역종양학 임상시험의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Immuno-oncology Clinical Trials will have significant change from previous year. By the most conservative estimates of global Immuno-oncology Clinical Trials market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in...

세계의 종양 치료용 약물 시장예측 2021년-2026년
LPI-2201K02116 / LP Information / 2021년 12월 / 본 조사보고서는 종양 치료용 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Oncology Drugs will have significant change from previous year. By the most conservative estimates of global Oncology Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 174700 million in 2020. Over...

세계의 단클론 항체 기반 시약 시장예측 2021년-2026년
LPI-2201K02231 / LP Information / 2021년 12월 / 본 조사보고서는 단클론 항체 기반 시약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Monoclonal Antibody Based Reagents will have significant change from previous year. By the most conservative estimates of global Monoclonal Antibody Based Reagents market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 펩타이드 기반 약물 시장예측 2021년-2026년
LPI-2201K02139 / LP Information / 2021년 12월 / 본 조사보고서는 펩타이드 기반 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Peptide-based Drug will have significant change from previous year. By the most conservative estimates of global Peptide-based Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 31480 million in 2020. Over...